Disease Treatment in Korea

Q: What side effects are common?

Usually transient: low-grade fever, chills or discomfort at the administration site. Report everything to the team.

Q: Why do prices differ so much?

Differences come from cell dose, number of sessions, testing depth and included services; compare line by line.

Q: Must follow-up happen in Korea?

Most follow-up can be done at home via labs, but agree in advance on sharing results with the Korean team.

Q: What does an unusually low price mean?

It may reflect a low cell count or an unregulated process; ask for written details.

Q: What if I am declined?

Treat it as useful information: refocus on standard care and ask about recruiting trials.

Q: Do donor cells carry infection risk?

Accredited facilities screen donors and test each lot rigorously; ask to see the documentation.

Q: What if the cells fail to reach target?

Recollection or rescheduling may be needed; clarify the cost policy for that before paying.

Q: Can they be combined?

Some providers offer that, but supporting evidence is thin; beware added cost without data.

Korea's world-leading disease treatment innovation — from cancer and cardiac care to neurosurgery and cell therapy.

In this category

Explainers, comparisons and guides for this category — not provider profiles.

Disease treatment in South Korea: among Asia's most advanced medical care

South Korea is one of Asia's most advanced centres for disease treatment, with cancer survival rates above the global average for several cancers and technologies such as proton beam therapy, da Vinci robotic surgery and MR-guided focused ultrasound in routine use at major Seoul hospitals. Costs run far below the United States, so international patient numbers grow every year, supported by full-service international desks with interpreters at tertiary hospitals like Asan, Samsung, Severance and Seoul National University Hospital.

Cover: a Korean nephrologist explaining a kidney model to a patient in a Seoul clinic

What is stem cell treatment for kidney disease? Kidney regeneration in Korea explained

Stem cell treatment for kidney disease means infusing mesenchymal stem cells (MSCs) with the aim of reducing inflammation and fibrosis in renal tissue, slowing decline and supporting functional kidney regeneration. In Korea the best-known example is EHL Bio's KDSTEM inj., which uses the patient's own urine-derived stem cells. It remains investigational, not standard care.

Cover: a doctor pointing at a kidney function trend chart on a tablet

The 5 stages of CKD: where kidney regeneration is still realistic and where it is not

CKD is staged by eGFR from stage 1 (90 or above) to stage 5 (below 15, usually requiring dialysis or transplant). Regenerative approaches are most plausible while functioning nephrons remain — broadly stages 2 to 4. At stage 5 the goal shifts to quality of life and renal replacement therapy.

Cover: a Korean researcher examining a protein sample under blue lab light

The Klotho protein and kidney regeneration: why Korean research focuses on it

Klotho is produced mainly in the kidney and acts as an antioxidant, anti-senescence, pro-angiogenic and phosphate-regulating protein. Its levels fall early in chronic kidney disease. Korean cell therapy research such as KDSTEM inj. therefore selects cells expressing high Klotho, on the hypothesis that they reduce oxidative stress and renal fibrosis.

Cover: a technician holding a rack of urine sample tubes in a sterile lab

Urine-derived stem cells (USC): how they are collected, cultured and studied for kidney disease

Urine-derived stem cells are urothelial-lineage cells shed naturally into urine that can be expanded into cells with mesenchymal stem cell-like properties. Their advantage is fully non-invasive collection — just a urine sample taken to protocol. Korean research turned them into KDSTEM inj. for chronic kidney disease, still in clinical development.

Cover: a middle-aged Korean man reflecting by a hospital window

Kidney regeneration is not a cure: set expectations before you spend

Kidney regeneration means helping the remaining kidney work better or decline more slowly. A cure means permanently normal kidney function, which nothing has proven in chronic kidney disease. Misplaced expectations are the main reason patients lose money to overstated offers.

Cover: a nurse preparing an IV line for a patient in a sterile procedure room

Step by step: stem cell injection for kidney disease in Korea, consult to follow-up

The pathway has five stages: send records and blood work for preliminary review, attend a consultation and repeat testing in Korea, provide the sample for GMP cell expansion, receive the scheduled intravenous infusions, then follow up on kidney markers at one, three and six months — all with nephrology input.

Cover: pre-treatment blood collection tubes on a stainless tray

What is tested before cell therapy: a preparation checklist for kidney treatment in Korea

Before any stem cell infusion for kidney disease you should have at least six sets of results: creatinine and eGFR, urine albumin-to-creatinine ratio, electrolytes and phosphate, a full blood count, hepatitis and HIV screening, and a renal ultrasound — plus a current medication list and full comorbidity history.

Cover: a treatment schedule calendar beside a medical vial on a desk

How many infusions and how far apart: dosing schedules in kidney stem cell therapy

Most renal stem cell protocols use repeat dosing because MSCs act by secreting anti-inflammatory factors rather than engrafting permanently, and infused cells are cleared fairly quickly. The actual number of sessions and intervals come from the study protocol and physician assessment, not from advertised figures.

Cover: a lab analyser processing blood and urine samples with result graphs

Measuring whether kidney regeneration worked: eGFR, proteinuria and endpoints you can trust

The main endpoints are the eGFR trend and the urine albumin-to-creatinine ratio, comparing a pre-treatment baseline with values at one, three and six months. A meaningful result is a flatter decline or a falling UACR — not how you feel, and not one isolated reading.

Cover: a GMP cleanroom technician working inside a biosafety cabinet

GMP standards and cell quality: what to verify before anyone infuses stem cells into you

Cells used for kidney treatment must be produced in a GMP facility with environmental control and per-batch testing for bacteria, fungi, mycoplasma and endotoxin, plus viability, purity and karyotype stability checks before release. Always ask to see the batch certificate of analysis.

Cover: a diabetic patient checking blood glucose at home

Diabetic kidney disease: how much can stem cell treatment realistically help?

Diabetic nephropathy comes from chronic hyperglycaemia damaging the kidney's capillaries, causing protein leakage and fibrosis. Care still rests on glucose and blood pressure control, SGLT2 inhibitors and ACEi/ARB. Stem cell infusion is an investigational adjunct aimed at inflammation and fibrosis, never a substitute for diabetes control.